Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19.
Zhu B, Wei X, Narasimhan H, Qian W, Zhang R, Cheon IS, Wu Y, Li C, Jones RG, Kaplan MH, Vassallo RA, Braciale TJ, Somerville L, Colca JR, Pandey A, Jackson PEH, Mann BJ, Krawczyk CM, Sturek JM, Sun J. Zhu B, et al. Among authors: sturek jm. Sci Immunol. 2023 Apr 14;8(82):eadf0348. doi: 10.1126/sciimmunol.adf0348. Epub 2023 Apr 14. Sci Immunol. 2023. PMID: 36821695 Free PMC article.
18F-NaF and 18F-FDG as molecular probes in the evaluation of atherosclerosis.
McKenney-Drake ML, Moghbel MC, Paydary K, Alloosh M, Houshmand S, Moe S, Salavati A, Sturek JM, Territo PR, Weaver C, Werner TJ, Høilund-Carlsen PF, Sturek M, Alavi A. McKenney-Drake ML, et al. Among authors: sturek jm, sturek m. Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2190-2200. doi: 10.1007/s00259-018-4078-0. Epub 2018 Jul 6. Eur J Nucl Med Mol Imaging. 2018. PMID: 29978245 Free PMC article. Review.
Convalescent plasma for preventing critical illness in COVID-19: A phase 2 trial and immune profile.
Sturek JM, Thomas TA, Gorham JD, Sheppard CA, Raymond AE, Guex KP, Harrington WB, Barros AJ, Madden GR, Alkabab YM, Lu D, Liu Q, Poulter MD, Mathers AJ, Thakur A, Kubicka EM, Lum LG, Heysell SK. Sturek JM, et al. medRxiv [Preprint]. 2021 Feb 19:2021.02.16.21251849. doi: 10.1101/2021.02.16.21251849. medRxiv. 2021. PMID: 33619508 Free PMC article. Updated. Preprint.
Quantitative measurement of IgG to SARS-CoV-2 proteins using ImmunoCAP.
Keshavarz B, Wiencek JR, Workman LJ, Straesser MD, Muehling LM, Canderan G, Drago F, Bonham CA, Sturek JM, Ramani C, McNamara CA, Woodfolk JA, Kadl A, Platts-Mills TAE, Wilson JM. Keshavarz B, et al. Among authors: sturek jm. medRxiv [Preprint]. 2020 Nov 12:2020.11.09.20228411. doi: 10.1101/2020.11.09.20228411. medRxiv. 2020. PMID: 33200147 Free PMC article. Updated. Preprint.
Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection.
Moreau GB, Burgess SL, Sturek JM, Donlan AN, Petri WA, Mann BJ. Moreau GB, et al. Among authors: sturek jm. Am J Trop Med Hyg. 2020 Sep;103(3):1215-1219. doi: 10.4269/ajtmh.20-0762. Am J Trop Med Hyg. 2020. PMID: 32723427 Free PMC article.
IL-13 is a driver of COVID-19 severity.
Donlan AN, Sutherland TE, Marie C, Preissner S, Bradley BT, Carpenter RM, Sturek JM, Ma JZ, Moreau GB, Donowitz JR, Buck GA, Serrano MG, Burgess SL, Abhyankar MM, Mura C, Bourne PE, Preissner R, Young MK, Lyons GR, Loomba JJ, Ratcliffe SJ, Poulter MD, Mathers AJ, Day AJ, Mann BJ, Allen JE, Petri WA Jr. Donlan AN, et al. Among authors: sturek jm. JCI Insight. 2021 Aug 9;6(15):e150107. doi: 10.1172/jci.insight.150107. JCI Insight. 2021. PMID: 34185704 Free PMC article.
Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial.
Sasson J, Donlan AN, Ma JZ, Haughey HM, Coleman R, Nayak U, Mathers AJ, Laverdure S, Dewar R, Jackson PEH, Heysell SK, Sturek JM, Petri WA Jr. Sasson J, et al. Among authors: sturek jm. medRxiv [Preprint]. 2022 May 19:2022.03.30.22273194. doi: 10.1101/2022.03.30.22273194. medRxiv. 2022. PMID: 35411349 Free PMC article. Updated. Preprint.
Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a Trial.
Sasson J, Donlan AN, Ma JZ, Haughey HM, Coleman R, Nayak U, Mathers AJ, Laverdure S, Dewar R, Jackson PEH, Heysell SK, Sturek JM, Petri WA Jr. Sasson J, et al. Among authors: sturek jm. Open Forum Infect Dis. 2022 Jul 27;9(8):ofac343. doi: 10.1093/ofid/ofac343. eCollection 2022 Aug. Open Forum Infect Dis. 2022. PMID: 35959207 Free PMC article.
41 results